109 related articles for article (PubMed ID: 37293759)
1. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and cancer mortality.
Tvingsholm SA; Dehlendorff C; Østerlind K; Friis S; Jäättelä M
Int J Cancer; 2018 Sep; 143(6):1315-1326. PubMed ID: 29658114
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
4. Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer.
Hálfdánarson ÓÖ; Pottegård A; Lund SH; Ogmundsdottir MH; Ogmundsdottir HM; Zoega H
Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):484-491. PubMed ID: 31872571
[TBL] [Abstract][Full Text] [Related]
5. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors.
Baek YH; Kang EJ; Hong S; Park S; Kim JH; Shin JY
Int J Cancer; 2022 Apr; 150(8):1291-1300. PubMed ID: 34877670
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.
Wang X; Liu Q; Halfdanarson ÓÖ; Zoega H; Sadr-Azodi O; Engstrand L; Fall K; Brusselaers N
Br J Cancer; 2021 Sep; 125(6):893-900. PubMed ID: 34253872
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
9. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
11. Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality.
Lo CH; Ni P; Yan Y; Ma W; Joshi AD; Nguyen LH; Mehta RS; Lochhead P; Song M; Curhan GC; Cao Y; Chan AT
Gastroenterology; 2022 Oct; 163(4):852-861.e2. PubMed ID: 35788344
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
13. Risk of Gynecomastia with Users of Proton Pump Inhibitors.
He B; Carleton B; Etminan M
Pharmacotherapy; 2019 May; 39(5):614-618. PubMed ID: 30865318
[TBL] [Abstract][Full Text] [Related]
14. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
15. Association between proton pump inhibitor use and anemia: a retrospective cohort study.
Sarzynski E; Puttarajappa C; Xie Y; Grover M; Laird-Fick H
Dig Dis Sci; 2011 Aug; 56(8):2349-53. PubMed ID: 21318590
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
[TBL] [Abstract][Full Text] [Related]
17. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
[TBL] [Abstract][Full Text] [Related]
18. Association of proton pump inhibitor use with the development of febrile neutropenia in lymphoma patients.
Hazzan R; Darawsha U; Neeman Z; Aviv A
Expert Rev Hematol; 2021 May; 14(5):503-507. PubMed ID: 33899663
[No Abstract] [Full Text] [Related]
19. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
[TBL] [Abstract][Full Text] [Related]
20. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
